A Phase I study of adjuvant chemotherapy with gemcitabine plus S-1 in patients with biliary tract cancer undergoing curative resection without major hepatectomy
Not Applicable
Recruiting
- Conditions
- Biliary tract cancer undergoing curative resection without major hepatectomy
- Registration Number
- JPRN-UMIN000007454
- Lead Sponsor
- Kansai Hepatobiliary Oncology Group (KHBO)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with resection of major hepatectomy 2) Patients with double cancers 3) Patients having severe allergy 4) Patients with severe organ dysfunction 5) Patients with active infectious disease 6) Pregnancy 7) Patients with severe psychological disease 8) Patients seem inadequate for this study by investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method